These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29766859)

  • 21. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantation of the Subcutaneous Implantable Cardioverter-Defibrillator: An Evaluation of 4 Implantation Techniques.
    Brouwer TF; Miller MA; Quast AB; Palaniswamy C; Dukkipati SR; Reddy V; Wilde AA; Willner JM; Knops RE
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):e004663. PubMed ID: 28073910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis.
    Koman E; Gupta A; Subzposh F; Saltzman H; Kutalek SP
    J Interv Card Electrophysiol; 2016 Mar; 45(2):219-23. PubMed ID: 26768264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The learning curve associated with the introduction of the subcutaneous implantable defibrillator.
    Knops RE; Brouwer TF; Barr CS; Theuns DA; Boersma L; Weiss R; Neuzil P; Scholten M; Lambiase PD; Leon AR; Hood M; Jones PW; Wold N; Grace AA; Olde Nordkamp LR; Burke MC;
    Europace; 2016 Jul; 18(7):1010-5. PubMed ID: 26324840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V; Moss AJ; Klein H; Biton Y; McNitt S; MacKecknie B; Zareba W; Goldenberg I
    Circulation; 2015 Oct; 132(17):1613-9. PubMed ID: 26316618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient characteristics and in-hospital complications of subcutaneous implantable cardioverter-defibrillator for Brugada syndrome in Japan.
    Kawamura I; Nakajima M; Kitamura T; Kaszynski RH; Hojo R; Ohbe H; Sasabuchi Y; Matsui H; Fushimi K; Fukamizu S; Yasunaga H
    J Arrhythm; 2019 Dec; 35(6):842-847. PubMed ID: 31844476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The subcutaneous implantable cardioverter and defibrillator: advantages, limitations and future directions.
    Verma N; Rhyner J; Knight BP
    Expert Rev Cardiovasc Ther; 2015; 13(9):989-99. PubMed ID: 26308601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD).
    Klein HU; Meltendorf U; Reek S; Smid J; Kuss S; Cygankiewicz I; Jons C; Szymkiewicz S; Buhtz F; Wollbrueck A; Zareba W; Moss AJ
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):353-67. PubMed ID: 19889186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy.
    Thienel M; Haum M; Sadoni S; Novotny J; Estner HL; Fichtner S; Lackermair K
    Patient Prefer Adherence; 2022; 16():3027-3033. PubMed ID: 36387054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ICD Outcome in Pediatric Cardiomyopathies.
    Silvetti MS; Tamburri I; Campisi M; Saputo FA; Cazzoli I; Cantarutti N; Cicenia M; Adorisio R; Baban A; Ravà L; Drago F
    J Cardiovasc Dev Dis; 2022 Jan; 9(2):. PubMed ID: 35200687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous Implantable Cardioverter Defibrillator Lead Failure due to Twiddler Syndrome.
    Kooiman KM; Brouwer TF; Van Halm VP; Knops RE
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1369-71. PubMed ID: 26306701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction.
    Russo V; Viani S; Migliore F; Nigro G; Biffi M; Tola G; Bisignani G; Dello Russo A; Sartori P; Rordorf R; Ottaviano L; Perego GB; Checchi L; Segreti L; Bertaglia E; Lovecchio M; Valsecchi S; Bongiorni MG
    Front Cardiovasc Med; 2021; 8():692943. PubMed ID: 34395560
    [No Abstract]   [Full Text] [Related]  

  • 35. Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry.
    Russo V; Rago A; Ruggiero V; Cavaliere F; Bianchi V; Ammendola E; Papa AA; Tavoletta V; De Vivo S; Golino P; D'Onofrio A; Nigro G
    Front Cardiovasc Med; 2022; 9():879918. PubMed ID: 35651910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defibrillators: Selecting the Right Device for the Right Patient.
    Al-Khatib SM; Friedman P; Ellenbogen KA
    Circulation; 2016 Nov; 134(18):1390-1404. PubMed ID: 27799257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
    Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
    Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subcutaneous implantable cardioverter-defibrillator: Initial experience.
    Galvão P; Cavaco D; Adragão P; Costa F; Carmo P; Morgado F; Bernardo R; Nunes M; Abecasis M; Neves J; Mendes M
    Rev Port Cardiol; 2014 Sep; 33(9):511-7. PubMed ID: 25242675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rate and impact on patient outcome and healthcare utilization of complications requiring surgical revision: Subcutaneous versus transvenous implantable defibrillator therapy.
    Palmisano P; Ziacchi M; Ammendola E; D'Onofrio A; Dell'Era G; Laffi M; Biffi M; Nigro G; Bianchi W; Prenna E; Angeletti A; Guido A; Stronati G; Gaggioli G; Dello Russo A; Accogli M; Guerra F;
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1712-1723. PubMed ID: 33969569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications associated with pectoral cardioverter-defibrillator implantation: comparison of subcutaneous and submuscular approaches. Worldwide Jewel Investigators.
    Gold MR; Peters RW; Johnson JW; Shorofsky SR
    J Am Coll Cardiol; 1996 Nov; 28(5):1278-82. PubMed ID: 8890827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.